Finance Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025November 18, 20250 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is without doubt one of the greatest small-cap biotech shares to purchase based on analysts. Edgewise…